Curanex Pharmaceuticals (CURX) Current Taxes (2024 - 2025)
Curanex Pharmaceuticals' (CURX) quarterly Current Taxes came in at $25.0 in Q2 2025, little changed quarter-over-quarter from $25.0 in Q4 2024.
Powered by 
Analysis
Curanex Pharmaceuticals (CURX) Current Taxes (2024 - 2025) Analysis & Trends
Curanex Pharmaceuticals (CURX) has reported Current Taxes for 2 consecutive years, with $25.0 the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Current Taxes changed N/A year-over-year to $25.0; the trailing twelve-month figure through Jun 2025 stood at $25.0 (changed N/A YoY), and the FY2024 full-year result was $25.0, changed N/A from the prior year.
- Current Taxes steadied at $25.0 in Q2 2025 per CURX's latest filing, from $25.0 in the prior quarter.
- Across five years, Current Taxes topped out at $25.0 in Q4 2024 and bottomed at $25.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Curanex Pharmaceuticals | 5.97 Mn | 3.03 Mn | - | - |